Kevin Outterson

Kevin Outterson is a lawyer, and the N. Neal Pike Scholar in Health and Disability Law at Boston University (2014–present). He is also the executive director of Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X),[1] a global non-profit partnership focused on development of antibiotics, diagnostics, vaccines and other products for drug-resistant bacterial infections. His work focuses primarily on law and economics of antibiotic resistance, health law, intellectual property, and global access to medicine.[1]

Kevin Outterson
Alma materNorthwestern University

University of Cambridge

University of Reading
OccupationLaw professor
EmployerBoston University School of Law
Known forHealth Law, Intellectual Property Law, Antibiotic Resistance

Outterson has testified before Congress, the World Health Organization (WHO), and various state legislatures.[2]

He is co-director of the health law program at Boston University School of Law (2007–present) and associate fellow at the Royal Institute of International Affairs at Chatham House, London (2014–present). He served on the Board of the American Society of Law, Medicine & Ethics, and serves as faculty editor to the American Journal of Law & Medicine (2007–present). He is past editor-in-chief of the Journal of Law, Medicine & Ethics (2010–2016).[1]

References
  1. "Kevin Outterson | School of Law". www.bu.edu. Retrieved 12 May 2020.
  2. "Professor Kevin Outterson". Chatham House. Retrieved 2020-05-01.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.